Context Therapeutics: Boral Capital raises PT to $9, maintains Buy rating.

martes, 24 de marzo de 2026, 3:01 pm ET1 min de lectura
CNTX--

Context Therapeutics: Boral Capital raises PT to $9, maintains Buy rating.

Context Therapeutics: Boral Capital raises PT to $9, maintains Buy rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios